Overview

It is not uncommon for experts in healthcare, bioengineering and the life sciences to lack familiarity with the fundamental principles of commerce and finance. Conversely, those responsible for financial decisions may lack familiarity with the intricacies of biomedical research and development processes. 'Navigating the Business Side of Biomedicine and Biotechnology' serves as an interdisciplinary bridge between these two sectors, offering an introductory exploration of the role played by the finance and business world in biotechnological healthcare delivery and drug development. By focusing on the interplay between scientific advancements, business models and financial frameworks, the author presents industry-specific terminologies and dynamics, thereby consolidating the nature of the interaction. The ten chapters of the book address specific financial concepts and their applications within the biomedical and healthcare industries. The necessity for 'Navigating the Business Side of Biomedicine and Biotechnology' arises from its consideration of the ongoing advancements in biotechnology, the industry's requirement for alternative business models and the challenges surrounding patient access. The intended audience for this publication includes those seeking to gain an understanding of the complexities of healthcare finance, biomedical experts seeking to comprehend the financial foundations of their field, other professionals in healthcare management and pharmaceuticals, researchers, regulators, policymakers, lawyers, patient advocates, patients, philanthropists and trade associations.